Professional Documents
Culture Documents
First Pediatric Patients Treated in T cell therapy Clinical Trial (CTL019, formerly CART19)
Promising early results of cell therapy to treat acute lymphoblastic leukemia and other B cell cancers
CTL019, a clinical trial of T cell therapy for patients with B cell cancers such as acute lymphoblastic leukemia (ALL), B cell non-Hodgkin lymphoma (NHL), and the adult disease chronic lymphocytic leukemia (CLL), has shown exciting early results for the first patients to be treated.
How to contact us
Review the following options for contacting CHOP about CTL019. To schedule an appointment or request a second opinion at CHOP, call 267-426-0762. If you have a pediatric patient or family member ages 1 to 21 years with B cell ALL or other B cell malignancies you may call 267-426-0762 or contact the Cancer Center online with questions, comments, feedback or requests for information about CTL019 and other clinical trials. If you are an adult patient or family member, please visit the Abramson Cancer Center online to learn more about this study and how to get more information. For more information about other open clinical trials at CHOP, search our Clinical Trials Search Tool.
While most childhood cancers are cured by standard treatment protocols, learning about the many new experimental therapies available at CHOP soon after diagnosis may keep more options open for patients who relapse.
extended period of time to continue controlling a patients disease stories of 2011. for the long-term. CTL019 reflects a solution to this last problem, making the trial unique compared to earlier forms of cell therapy.
Contact Us
Existing patients or family members, please call
215-590-3025 267-426-0762
1996-2013 The Children's Hospital of Philadelphia 34th Street and Civic Center Boulevard Philadelphia, Pa. 19104 Main Num ber : 215-590-1000 Physician Referral Service : 1-800-879-2467 Coordinates : 39.9486937, -75.1929596 An Equal Opportunity Em ployer The Children's Hospital of Philadelphia is an equal opportunity employer. We do not discriminate on the basis of race, color, gender, sexual orientation, age, religion, national or ethnic origin, disability or
veteran status.